Literature DB >> 1550989

The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells.

N Le Marer1, V Laudet, E C Svensson, H Cazlaris, B Van Hille, C Lagrou, D Stehelin, J Montreuil, A Verbert, P Delannoy.   

Abstract

Alteration in cell surface carbohydrates, and in particular cell surface sialylation, have been known to occur during oncogenic transformation. To examine the basis for such changes, we have transformed the rat fibroblast cell line FR3T3 with the oncogenes c-Ha-ras EJ, v-mycOK10, v-src, polyoma virus middle T or the transforming bovine papilloma virus 1 (BPV1), and measured the sialytransferase activities of cellular lysates. We found that, in contrast to all other oncogenes examined, c-Ha-ras induced a striking increase in beta-galactoside alpha-2,6-sialytransferase (Gal alpha-2,6-ST) activity in FR3T3 cells. This increase in Gal alpha-2,6-ST activity resulted in the increased expression of cell surface alpha-2,6-linked sialic acid on cell surface glycoconjugates, as determined by cell staining with fluorescein-labelled Sambucus nigra agglutinin. Immunoprecipitation and immunofluorescence experiments revealed that the increase in Gal alpha-2,6-ST activity was due to an elevation of expression of the enzyme. Moreover, Northern analysis suggested that the increased expression of this enzyme was the result of an increase in the steady-state mRNA level of the Gal alpha-2,6-ST gene. These results support the notion that alterations seen in cell surface glycoconjugates during oncogenic transformation can be the result of altered expression of glycosyltransferases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550989     DOI: 10.1093/glycob/2.1.49

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  27 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

3.  Evidence for a correlation between ambient cholesterol levels and soluble plasma sialyltransferase enzyme activity.

Authors:  T M Maguire; M F Ryan; K C Breen
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

4.  Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells.

Authors:  M A Recchi; A Harduin-Lepers; Y Boilly-Marer; A Verbert; P Delannoy
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

5.  Differentiation -dependent expression of human beta-galactoside alpha 2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells.

Authors:  F Dall'Olio; N Malagolini; S Guerrini; J T Lau; F Serafini-Cessi
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

Review 6.  Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential.

Authors:  M Pierce; P Buckhaults; L Chen; N Fregien
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

7.  Sialyltransferase activity in FR3T3 cells transformed with ras oncogene: decreased CMP-Neu5Ac:Gal beta 1-3GalNAc alpha-2,3-sialyltransferase.

Authors:  P Delannoy; H Pelczar; V Vandamme; A Verbert
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

Review 8.  Glycosylation at the fetomaternal interface: does the glycocode play a critical role in implantation?

Authors:  Carolyn J P Jones; John D Aplin
Journal:  Glycoconj J       Date:  2008-08-03       Impact factor: 2.916

Review 9.  Tumour-associated carbohydrate antigens in breast cancer.

Authors:  Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy
Journal:  Breast Cancer Res       Date:  2010-06-08       Impact factor: 6.466

10.  Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.

Authors:  Faheem M Shaikh; Eric C Seales; William C Clem; Kristin M Hennessy; Ya Zhuo; Susan L Bellis
Journal:  Exp Cell Res       Date:  2008-07-30       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.